MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators in human cancer development, including colorectal cancer (CRC).
• The specific roles and mechanisms of many miRNAs in CRC progression require further elucidation.
• Understanding miRNA functions is vital for identifying novel diagnostic and therapeutic targets in CRC.

Purpose of the Study:

• To investigate the biological function and molecular mechanism of miR-208a-3p in colorectal cancer.
• To identify potential downstream targets of miR-208a-3p involved in CRC pathogenesis.
• To evaluate miR-208a-3p as a potential biomarker for CRC diagnosis and therapy.

Main Methods:

• Microarray analysis to identify differentially expressed miRNAs in CRC tissues.
• Functional assays (proliferation, invasion, migration, apoptosis) to assess miR-208a-3p's role in CRC cells.
• Target validation using luciferase reporter assays and Western blotting to confirm PDCD4 as a direct target.

Main Results:

• miR-208a-3p was significantly upregulated in CRC tissues and associated with advanced TNM stage and distant metastasis.
• Inhibition of miR-208a-3p suppressed CRC cell proliferation, invasion, and migration, while inducing apoptosis.
• miR-208a-3p directly targets and downregulates the tumor suppressor programmed cell death protein 4 (PDCD4).
• PDCD4 overexpression inhibited CRC cell growth, and its silencing reversed the effects of miR-208a-3p inhibition.

Conclusions:

• miR-208a-3p acts as an oncogene in colorectal cancer by targeting PDCD4.
• The miR-208a-3p/PDCD4 axis plays a critical role in promoting CRC progression.
• miR-208a-3p represents a promising diagnostic and therapeutic biomarker for colorectal cancer.